Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions
Elie G. Dib: How Long Does Maintenance Therapy Actually Need to Last?
Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC
Hope for Stomach Cancer and OncoDaily Announce Strategic Media Partnership
Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy
TOPAZ-1 Post Hoc Analysis: Durvalumab Plus GemCis in Advanced Biliary Tract Cancer
Asparaginase Drug Monitoring in Pediatric ALL: The Brazilian Experience - Resonance
KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer
The MSCO 2025 Annual Meeting, hosted by the Massachusetts Society of Clinical Oncologists (MSCO), is a specialized evening event scheduled for November 14, 2025, from 5:30 PM to 8:45 PM, […]
